Trial Profile
An observation, real-life trial to assess vildagliptin, vs oral antihyperglycaemics, in combination with oral antihyperglycaemic monotherapy in patients with type 2 diabetes mellitus inqdeuately controlled with one oral antihyperglycaemic.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 21 Jan 2020
Price :
$35
*
At a glance
- Drugs Vildagliptin (Primary) ; Antihyperglycaemics; Metformin; Sulfonylureas
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions; Therapeutic Use
- Acronyms EDGE
- 06 Dec 2019 Results, assessing recruitment patterns on gender basis from the data of two clinical trials (VERIFY and EDGE), presented at the 2019 Congress of the International Diabetes Federation
- 22 May 2019 Data from this study was employed to compare the outcomes obtained with general Framingham against end-point Framingham (EPF) equations; result presented at the 24th Annual International Meeting of the International Society for Pharmacoeconomics and Outcomes Research
- 01 Aug 2017 Results of a post-hoc analysis published in the Diabetes Therapy.